Long-term outcomes of continuous intrathecal baclofen infusion for treatment of spasticity: A prospective multicenter follow-up study

Neuromodulation

Volumn 11, Issue 3, 2008, Pages 227-236

  Delhaas, Elmar M ^a   Beersen, Nicoline ^b   Redekop, W Ken ^b   Klazinga, Niek S ^c  

^a AMPHIA HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Baclofen; Complications; Implantable infusion pumps; Muscle spasticity; Patient dropouts

Indexed keywords

BACLOFEN; SPASMOLYTIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CATHETERIZATION; CLINICAL FEATURE; CLONUS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; FOLLOW UP; FUNCTIONAL INDEPENDENCE MEASURE; HUMAN; IMPLANTATION; INFECTION; LIQUORRHEA; LONG TERM CARE; MAJOR CLINICAL STUDY; MENINGITIS; PROSPECTIVE STUDY; QUALITY OF LIFE; SCORING SYSTEM; SCREENING TEST; SELF REPORT; SPASTICITY; TREATMENT OUTCOME;

EID: 47349110023     PISSN: 10947159     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2008.00170.x     Document Type: Article

References (40)

1. Plassat R, Perrouin Verbe B, Menei P, Menegalli D, Mathe JF, Richard I. Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 2004 42:686 693.
2. Zahavi A, Geertzen JH, Middel B, Staal M, Rietman JS. Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry 2004 75:1553 1557.
3. Rawicki B. Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: long-term follow-up review of 18 patients. J Neurosurg 1999 91:733 736.
4. Vidal J, Fenollosa P, Martin E et al. Safety and efficacy of intrathecal baclofen infusion by implantable pump for the treatment of severe spinal spasticity: a Spanish Multicenter study. Neuromodulation 2000 3:175 182.
5. Beersen N, de Bruijn JHB, Dekkers MA et al. Developing a national continuous quality improvement system for neuromodulation treatment in The Netherlands. Jt Comm J Qual Saf 2004 30:310 321.
6. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964 192:540 542.
7. Penn RD, Kroin JS. Continuous intrathecal baclofen for severe spasticity. Lancet 1985 2:125 127.
8. Muller H, Sarges R, Jouaux J, Runte W, Lampante L. [Intraoperative suppression of spasticity using intrathecal baclofen]. Anaesthesist 1990 39:22 25.
9. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981 19:787 805.
10. Gianino JM, York MM, Paice JA, Shott S. Quality of life: effect of reduced spasticity from intrathecal baclofen. J Neurosci Nurs 1998 30:47 54.
11. Bruijn de AF, Diedericks JPM, Witte LP, Stevens FCJ, Philipsen H. SIP-68: a shortened version of the sickness impact profile. Maastricht, The Netherlands:Rijksuniversiteit Limburg, vakgroep Medische Microbiologie, 1994
12. Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996 77:35 39.
13. Dario A, Di Stefano MG, Grossi A, Casagrande F, Bono G. Long-term intrathecal Baclofen infusion in supraspinal spasticity of adulthood. Acta Neurol Scand 2002 105:83 87.
14. Granger CV, Hamilton BB. UDS report: the uniform data system for medical rehabilitation report of first admissions for 1990. Am J Phys Med Rehabil 1992 71:108 113.
15. Steinbok P. Outcomes after selective dorsal rhizotomy for spastic cerebral palsy. Childs Nerv Syst 2001 17:1 18.
16. Brooks R. EuroQol: the current state of play. Health Policy 1996 37:53 72.
17. Busschbach JJ, McDonnell J, Essink-Bot ML, van Hout BA. Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5D. J Health Econ 1999 18:551 571.
18. Samuel M, Finnerty GT, Rudge P. Intrathecal baclofen pump infection treated by adjunct intrareservoir antibiotic instillation. J Neurol Neurosurg Psychiatry 1994 57:1146 1147.
19. Zed PJ, Stiver HG, Devonshire V, Jewesson PJ, Marra F. Continuous intrathecal pump infusion of baclofen with antibiotic drugs for treatment of pump-associated meningitis. Case report. J Neurosurg 2000 92:347 349.
20. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999 341:137 141.
21. Armstrong RW. Intrathecal baclofen and spasticity: what do we know and what do we need to know? Dev Med Child Neurol 1992 34:739 745.
22. Middel B, Kuipers-Upmeijer H, Bouma J et al. Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 1997 63:204 209.
23. Guillaume D, Van Havenbergh A, Vloeberghs M, Vidal J, Roeste G. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. Arch Phys Med Rehabil 2005 86:2165 2171.
24. Albright AL. Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 1996 11 (Suppl. 1 S29 S35.
25. Loubser PG, Narayan RK, Sandin KJ, Donovan WH, Russell KD. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 1991 29:48 64.
26. Albright AL, Turner M, Pattisapu JV. Best-practice surgical techniques for intrathecal baclofen therapy. J Neurosurg 2006 104:233 239.
27. Follett KA, Burchiel K, Deer T et al. Prevention of intrathecal drug delivery catheter-related complications. Neuromodulation 2003 6:32 41.
28. Reeves RK, Stolp-Smith KA, Christopherson MW. Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. Arch Phys Med Rehabil 1998 79:353 356.
29. Green LB, Nelson VS. Death after acute withdrawal of intrathecal baclofen: case report and literature review. Arch Phys Med Rehabil 1999 80:1600 1604.
30. Al-Khodairy AT, Vuagnat H, Uebelhart D. Symptoms of recurrent intrathecal baclofen withdrawal resulting from drug delivery failure: a case report. Am J Phys Med Rehabil 1999 78:272 277.
31. Coffey RJ, Ridgely PM. Abrupt intrathecal baclofen withdrawal: management of potentially life-threatening sequelae. Neuromodulation 2001 4:142 146.
32. Alden TD, Lytle RA, Park TS, Noetzel MJ, Ojemann JG. Intrathecal baclofen withdrawal: a case report and review of the literature. Childs Nerv Syst 2002 18:522 525.
33. Coffey RJ, Edgar TS, Francisco GE et al. Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 2002 83:735 741.
34. Greenberg MI, Hendrickson RG. Baclofen withdrawal following removal of an intrathecal baclofen pump despite oral baclofen replacement. J Toxicol Clin Toxicol 2003 41:83 85.
35. Kopell BH, Sala D, Doyle WK, Feldman DS, Wisoff JH, Weiner HL. Subfascial implantation of intrathecal baclofen pumps in children: technical note. Neurosurgery 2001 49:753 756 discussion 756-757.
36. Wunderlich CA, Krach LE. Gram-negative meningitis and infections in individuals treated with intrathecal baclofen for spasticity: a retrospective study. Dev Med Child Neurol 2006 48:450 455.
37. Shirley KW, Kothare S, Piatt JH Jr, Adirim TA. Intrathecal baclofen overdose and withdrawal. Pediatr Emerg Care 2006 22:258 261.
38. Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. The management of neurosurgical patients with postoperative bacterial or aseptic meningitis or external ventricular drain-associated ventriculitis. Br J Neurosurg 2000 14:7 12.
39. Boviatsis EJ, Kouyialis AT, Boutsikakis I, Korfias S, Sakas DE. Infected CNS infusion pumps. Is there a chance for treatment without removal? Acta Neurochir (Wien) 2004 146:463 467.
40. Atiyeh BS, Hayek SN, Skaf GS, Al Araj A, Chamoun RB. Baclofen pump pocket infection: a case report of successful salvage with muscle flap. Int Wound J 2006 3:23 28.